NASDAQ
CLVR

Clever Leaves Holdings Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Clever Leaves Holdings Inc Stock Price

Vitals

Today's Low:
$3.5
Today's High:
$4.07
Open Price:
$3.9
52W Low:
$0.235
52W High:
$1.46
Prev. Close:
$3.9
Volume:
154490

Company Statistics

Market Cap.:
$11.63 million
Book Value:
0.836
Revenue TTM:
$16.74 million
Operating Margin TTM:
-163.79%
Gross Profit TTM:
$6.81 million
Profit Margin:
0%
Return on Assets TTM:
-19.76%
Return on Equity TTM:
-94.77%

Company Profile

Clever Leaves Holdings Inc had its IPO on 2020-12-18 under the ticker symbol CLVR.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Clever Leaves Holdings Inc has a staff strength of 400 employees.

Stock update

Shares of Clever Leaves Holdings Inc opened at $3.9 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.5 - $4.07, and closed at $3.55.

This is a -8.97% slip from the previous day's closing price.

A total volume of 154,490 shares were traded at the close of the day’s session.

In the last one week, shares of Clever Leaves Holdings Inc have slipped by -17.44%.

Clever Leaves Holdings Inc's Key Ratios

Clever Leaves Holdings Inc has a market cap of $11.63 million, indicating a price to book ratio of 0.2796 and a price to sales ratio of 1.0032.

In the last 12-months Clever Leaves Holdings Inc’s revenue was $16.74 million with a gross profit of $6.81 million and an EBITDA of $-24015000. The EBITDA ratio measures Clever Leaves Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clever Leaves Holdings Inc’s operating margin was -163.79% while its return on assets stood at -19.76% with a return of equity of -94.77%.

In Q1, Clever Leaves Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 21.1%.

Clever Leaves Holdings Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clever Leaves Holdings Inc’s profitability.

Clever Leaves Holdings Inc stock is trading at a EV to sales ratio of 0.4113 and a EV to EBITDA ratio of -0.1296. Its price to sales ratio in the trailing 12-months stood at 1.0032.

Clever Leaves Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$46.24 million
Total Liabilities
$7.80 million
Operating Cash Flow
$0
Capital Expenditure
$35000
Dividend Payout Ratio
0%

Clever Leaves Holdings Inc ended 2024 with $46.24 million in total assets and $0 in total liabilities. Its intangible assets were valued at $46.24 million while shareholder equity stood at $36.77 million.

Clever Leaves Holdings Inc ended 2024 with $0 in deferred long-term liabilities, $7.80 million in other current liabilities, in common stock, $-184986000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.36 million and cash and short-term investments were $6.36 million. The company’s total short-term debt was $1,056,000 while long-term debt stood at $1.02 million.

Clever Leaves Holdings Inc’s total current assets stands at $21.13 million while long-term investments were $5.75 million and short-term investments were $0. Its net receivables were $4.79 million compared to accounts payable of $1.78 million and inventory worth $8.02 million.

In 2024, Clever Leaves Holdings Inc's operating cash flow was $0 while its capital expenditure stood at $35000.

Comparatively, Clever Leaves Holdings Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$3.55
52-Week High
$1.46
52-Week Low
$0.235
Analyst Target Price
$0.8

Clever Leaves Holdings Inc stock is currently trading at $3.55 per share. It touched a 52-week high of $1.46 and a 52-week low of $1.46. Analysts tracking the stock have a 12-month average target price of $0.8.

Its 50-day moving average was $5.92 and 200-day moving average was $9.41 The short ratio stood at 2.1 indicating a short percent outstanding of 0%.

Around 1308.4% of the company’s stock are held by insiders while 1528.5% are held by institutions.

Frequently Asked Questions About Clever Leaves Holdings Inc

The stock symbol (also called stock or share ticker) of Clever Leaves Holdings Inc is CLVR

The IPO of Clever Leaves Holdings Inc took place on 2020-12-18

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$12
0.57
+4.99%
$66.15
3.1
+4.92%
$19.12
-2.09
-9.85%
Kao Corp ADR (KAOOY)
$7.59
0.02
+0.26%
$0.03
-0.07
-65.98%
$5.05
-0.19
-3.63%
$0
0
+15%
$0.02
-0
-23%
$400.55
-8.15
-1.99%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.

Address

6501 Congress Avenue, Boca Raton, FL, United States, 33487